Czech National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
25,384
+1,220
| +5% | +$641K | 0.1% | 178 |
|
|
2025
Q1 | $15.3M | Buy |
24,164
+1,338
| +6% | +$849K | 0.14% | 141 |
|
|
2024
Q4 | $16.3M | Buy |
22,826
+1,209
| +6% | +$861K | 0.15% | 125 |
|
|
2024
Q3 | $22.7M | Buy |
21,617
+1,405
| +7% | +$1.48M | 0.23% | 84 |
|
|
2024
Q2 | $21.2M | Buy |
20,212
+1,624
| +9% | +$1.71M | 0.24% | 81 |
|
|
2024
Q1 | $17.9M | Sell |
18,588
-178
| -0.9% | -$171K | 0.23% | 92 |
|
|
2023
Q4 | $16.5M | Buy |
18,766
+109
| +0.6% | +$95.7K | 0.24% | 94 |
|
|
2023
Q3 | $15.4M | Buy |
18,657
+5,885
| +46% | +$4.84M | 0.24% | 87 |
|
|
2023
Q2 | $9.18M | Buy |
12,772
+107
| +0.8% | +$76.9K | 0.21% | 101 |
|
|
2023
Q1 | $10.4M | Buy |
12,665
+131
| +1% | +$108K | 0.26% | 89 |
|
|
2022
Q4 | $9.04M | Buy |
12,534
+77
| +0.6% | +$55.6K | 0.24% | 99 |
|
|
2022
Q3 | $8.58M | Buy |
+12,457
| New | +$8.58M | 0.25% | 88 |
|